The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Janux Therapeutics, Inc. insider acquisitions

Company CIK 0001817713 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
JANX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 22, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Doyle Janeen NoelDoyle Janeen NoelMcIver ZachariahMcIver ZachariahDobek MariaDobek MariaDiRaimondo ThomasDiRaimondo ThomasWinter Charles M.Winter Charles M.Campbell David AlanCampbell David AlanMeyer Andrew HollmanMeyer Andrew HollmanDoyle Janeen Noel · January 2, 2026 · Stock award · Stock option (right to buy)Doyle Janeen Noel · January 2, 2026 · Stock award · Common StockMcIver Zachariah · January 2, 2026 · Stock award · Stock option (right to buy)McIver Zachariah · January 2, 2026 · Stock award · Common StockDobek Maria · January 2, 2026 · Stock award · Stock option (right to buy)Dobek Maria · January 2, 2026 · Stock award · Common StockDiRaimondo Thomas · January 2, 2026 · Stock award · Stock option (right to buy)DiRaimondo Thomas · January 2, 2026 · Stock award · Common StockWinter Charles M. · January 2, 2026 · Stock award · Stock option (right to buy)Winter Charles M. · January 2, 2026 · Stock award · Common StockCampbell David Alan · January 2, 2026 · Stock award · Stock option (right to buy)Campbell David Alan · January 2, 2026 · Stock award · Common StockMeyer Andrew Hollman · December 1, 2025 · Exercise / conversion · Common StockMeyer Andrew Hollman · November 14, 2025 · Exercise / conversion · Common StockMeyer Andrew Hollman · October 28, 2025 · Exercise / conversion · Common StockMeyer Andrew Hollman · October 28, 2025 · Exercise / conversion · Common StockOct 28, 2025Jan 2, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

16 dated transactions · 7 of 7 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Jan 2, 2026Janux Therapeutics, Inc.Stock option (right to buy)Doyle Janeen NoelStock award
Jan 2, 2026Janux Therapeutics, Inc.Common StockDoyle Janeen NoelStock award
Jan 2, 2026Janux Therapeutics, Inc.Stock option (right to buy)McIver ZachariahStock award
Jan 2, 2026Janux Therapeutics, Inc.Common StockMcIver ZachariahStock award
Jan 2, 2026Janux Therapeutics, Inc.Stock option (right to buy)Dobek MariaStock award
Jan 2, 2026Janux Therapeutics, Inc.Common StockDobek MariaStock award
Jan 2, 2026Janux Therapeutics, Inc.Stock option (right to buy)DiRaimondo ThomasStock award
Jan 2, 2026Janux Therapeutics, Inc.Common StockDiRaimondo ThomasStock award
Jan 2, 2026Janux Therapeutics, Inc.Stock option (right to buy)Winter Charles M.Stock award
Jan 2, 2026Janux Therapeutics, Inc.Common StockWinter Charles M.Stock award
Jan 2, 2026Janux Therapeutics, Inc.Stock option (right to buy)Campbell David AlanStock award
Jan 2, 2026Janux Therapeutics, Inc.Common StockCampbell David AlanStock award
Dec 1, 2025Janux Therapeutics, Inc.Common StockMeyer Andrew HollmanExercise / conversion
Nov 14, 2025Janux Therapeutics, Inc.Common StockMeyer Andrew HollmanExercise / conversion
Oct 28, 2025Janux Therapeutics, Inc.Common StockMeyer Andrew HollmanExercise / conversion
Oct 28, 2025Janux Therapeutics, Inc.Common StockMeyer Andrew HollmanExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

JANX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr
Stock awardStock option (right to buy)Derivative security · Code A126,0000Value: 0Currency not specifiedView ↗
Trade:
Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr
Stock awardCommon StockNon-derivative security · Code A36,0000Value: 0Currency not specifiedView ↗
Trade:
McIver ZachariahChief Medical Officer
Stock awardStock option (right to buy)Derivative security · Code A101,5000Value: 0Currency not specifiedView ↗
Trade:
McIver ZachariahChief Medical Officer
Stock awardCommon StockNon-derivative security · Code A29,0000Value: 0Currency not specifiedView ↗
Trade:
Dobek MariaVice President, Accounting
Stock awardStock option (right to buy)Derivative security · Code A42,6000Value: 0Currency not specifiedView ↗
Trade:
Dobek MariaVice President, Accounting
Stock awardCommon StockNon-derivative security · Code A18,9350Value: 0Currency not specifiedView ↗
Trade:
DiRaimondo ThomasChief Scientific Officer
Stock awardStock option (right to buy)Derivative security · Code A109,9000Value: 0Currency not specifiedView ↗
Trade:
DiRaimondo ThomasChief Scientific Officer
Stock awardCommon StockNon-derivative security · Code A31,4000Value: 0Currency not specifiedView ↗
Trade:
Winter Charles M.Chief Technical Officer
Stock awardStock option (right to buy)Derivative security · Code A100,1000Value: 0Currency not specifiedView ↗
Trade:
Winter Charles M.Chief Technical Officer
Stock awardCommon StockNon-derivative security · Code A28,6000Value: 0Currency not specifiedView ↗
Trade:
Campbell David AlanPresident and CEO · Director
Stock awardStock option (right to buy)Derivative security · Code A338,1000Value: 0Currency not specifiedView ↗
Trade:
Campbell David AlanPresident and CEO · Director
Stock awardCommon StockNon-derivative security · Code A96,6000Value: 0Currency not specifiedView ↗
Trade:
Meyer Andrew HollmanChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,33310.59Value: 35,296.47Currency not specifiedView ↗
Trade:
Meyer Andrew HollmanChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M3,33310.59Value: 35,296.47Currency not specifiedView ↗
Trade:
Meyer Andrew HollmanChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M6,66610.59Value: 70,592.94Currency not specifiedView ↗
Trade:
Meyer Andrew HollmanChief Business Officer
Exercise / conversionCommon StockNon-derivative security · Code M9,9994.21Value: 42,095.79Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →